Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Coordination and Support Action · Running

4.UNCAN.eu A Coordination and Support Action to prepare UNCAN.eu platform

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 September 2022 to 30 November 2023
Status
Running
EU funding
€3.0m
Total cost
€3.0m
Partners
31 organisations in 20 countries
Type
Coordination and Support Action
Grant agreement
101069496

What the project is doing

In the project's own words, from its summary on CORDIS.

The 15-month coordination and support action “4.UNCAN.eu” will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNderstand CANcer proposed by the Mission Board and the European Beating Cancer Plan. This research agenda will be built with the final aim of achieving a new breakthrough in cancer prevention and treatment that will contribute to saving European citizens’ lives and help ensuring an optimal quality of life to disease survivors.

To reach a new level of understanding, UNCAN.eu will take advantage of recent advances in research data generation and data sciences. Reliable, high-quality cancer research data generated by experimental model analysis and collected from longitudinal follow-up of cancer patients will be shared and integrated at an unprecedented scale within a Federated Cancer Research data hub, in the context of the General Data Protection Regulation.

This information will be used by relevant players in Europe and beyond to address urgent and essential scientific and medical challenges in cancer prevention, early diagnosis, treatment and survivorship, in males and females of various ages. These challenges, identified in close interaction with European patients and citizens, will be tackled through competitive, ambitious and innovative, cross-border and trans-disciplinary research programmes built in a problem-solving manner.

The definition of challenges will integrate inequalities in cancer research across regions and member states in order to boost the research potential of less-developed regions in Europe. Players will be committed to open science principles, including FAIR (findable, accessible, interoperable, and reusable) guiding principles for scientific data collection, management and stewardship. The new understanding gained from the collection and analysis of this wealth of data will apply secondarily to other diseases.

Topics

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator
Medizinische Universitaet WienWienAustriaParticipant
European Cancer Patient CoalitionBruxelles / BrusselBelgiumParticipant
Organisation of European Cancer InstitutesBruxelles / BrusselBelgiumParticipant
SciensanoElseneBelgiumParticipant
Siop EuropeBruxelles / BrusselBelgiumParticipant
Masarykuv Onkologicky UstavBrnoCzechiaParticipant
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Region Nordjylland (north Denmark Region)AalborgDenmarkParticipant
Tartu UlikoolTartuEstoniaParticipant
Consorcio Centro De Investigacion Biomedica En Red M.p.MadridSpainParticipant
Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio)BarcelonaSpainParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Centre International De Recherche Sur Le CancerLyon 7emeFranceParticipant
Inserm Transfert SAParisFranceParticipant
Institut National Du Cancer GipBoulogne BillancourtFranceParticipant
Universite Paris-SaclayGif-Sur-YvetteFranceThird party
Orszagos Onkologiai IntezetBudapestHungaryParticipant
University College Dublin, National University of Ireland, DublinDublinIrelandParticipant
Alleanza Contro Il CancroRomaItalyParticipant
Vilniaus Universiteto Ligonine Santaros KlinikosVilniusLithuaniaParticipant
Luxembourg Institute of HealthStrassenLuxembourgParticipant
Office of the Deputy Prime Minister and Ministry for HealthVallettaMaltaParticipant
Childhood Cancer InternationalAmsterdamNetherlandsParticipant
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek ZiekenhuisAmsterdamNetherlandsParticipant
Stichting Integraal Kankercentrum NederlandUtrechtNetherlandsThird party
Stichting Oncode InstituteUtrechtNetherlandsParticipant
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut BadawczyWarszawaPolandParticipant
Instituto Portugues De Oncologia Do Porto Francisco Gentil, EpePortoPortugalParticipant
Kemijski InstitutLjubljanaSloveniaParticipant
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna InstituciaBratislavaSlovakiaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI